Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dong'e Ejiao for decreased ovarian function (blood deficiency syndrome)
ChiCTR2200063324Phase 4Completed
- Sponsor
- Beijing Hospital of Traditional Chinese Medicine
- Start
- Apr 2022
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Diminished Ovarian Reserve (DOR), ovarian hypofunction (POI) and primary ovarian insufficiency (POI) comparing Dong'e Ejiao with Placebo mimetic (2 arms). Primary endpoint: Modified Kupperman Score. Started Apr 2022; status: completed.
02
Drugs
colla corii asini
03
Conditions
Diminished Ovarian Reserve (DOR)ovarian hypofunction (POI)primary ovarian insufficiency (POI)
Beyond the preview
Go deeper on ChiCTR2200063324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063324.